Nonalcoholic Steatohepatitis Completed Phase 2 Trials for Pentoxifylline (DB00806)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00590161Pentoxifylline in Patients With Nonalcoholic SteatohepatitisTreatment